https://www.selleckchem.com/pr....oducts/pf-07265807.h
To investigate the comparative effectiveness of dopamine agonists and monoamine oxidase type-B (MAO- inhibitors available for treatment of Parkinson's disease. We performed a systematic literature search identifying randomized controlled trials investigating 4 dopamine agonists (cabergoline, pramipexole, ropinirole, rotigotine) and 3 MAO-B inhibitors (selegiline, rasagiline, safinamide) for Parkinson's disease. We extracted and pooled data from included clinical trials in a joint model allowing both direct and indirect comparison
Like
Comment
Share
